Hải Lê Thị Thu, Phương Bùi Thị Thu, Minh Phạm Ngọc, Firas Al-Niaimi
108 Central Military Hospital, Hanoi, Vietnam.
Aalborg University Hospital, Aalborg, Denmark.
Lasers Med Sci. 2025 Jan 24;40(1):41. doi: 10.1007/s10103-024-04230-9.
Hemangiomas are common benign vascular tumors that often present in childhood. The 595 nm pulsed dye laser (PDL) is now being widely used to treat vascular skin lesions. This case series was performed to review the therapeutic efficacy and safety of PDL in the treatment of hemangiomas among Vietnamese patients. A total of 43 Vietnamese patients (79.1% females), mean age was 8.83 years old (2 months - 54 years old), with a clinical diagnosis of hemangioma, were treated with the PDL over 2 years. Treatments were performed every 4 weeks. Hemangioma lesions that occur on the head and the neck are seen in 65.1%, 67.4% of superficial, and 32.6% of mixed hemangioma subtypes. The mean treatment is 5.3 times. Excellent-good results were achieved in 86.1%, average results in 11.6%. No permanent side effects during the treatments were observed. Treatment of hemangiomas using the 595 nm PDL is an effective and safe method in the skin types of Vietnamese patients. The effect does require several treatment sessions.
血管瘤是常见的良性血管肿瘤，常在儿童期出现。595纳米脉冲染料激光（PDL）目前被广泛用于治疗皮肤血管病变。本病例系列旨在回顾PDL治疗越南患者血管瘤的疗效和安全性。在两年多的时间里，共有43例临床诊断为血管瘤的越南患者（79.1%为女性）接受了PDL治疗，平均年龄为8.83岁（2个月至54岁）。治疗每4周进行一次。65.1%的血管瘤病变发生在头颈部，浅表型血管瘤占67.4%，混合型血管瘤占32.6%。平均治疗次数为5.3次。86.1%的患者取得了优-良效果，11.6%的患者效果一般。治疗期间未观察到永久性副作用。对于越南患者的皮肤类型，使用595纳米PDL治疗血管瘤是一种有效且安全的方法。不过该效果确实需要多次治疗。
